Crossmark

Immunogenicity of BNT162b2 vaccine after two and three doses in health personnel and institutionalized elderly people not infected with SARS-CoV-2

Crossref DOI link: https://doi.org/10.1016/j.semerg.2023.102092

Published Print: 2024-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rodríguez-Prieto, M.

Modino-García, F.

de la Arada-Benavides, C.

de la Puente, R.

Carvajal, A.

Rodríguez-Cabañeros, I.

de Prado-Santos, C.

de Mota-Luna, B.

Fernández-Villa, T.

Fernández-Váquez, J.P.

Martín, V.
License Information

Text and Data Mining valid from 2024-01-01
More Information

This article is maintained by: Elsevier

Article Title: Immunogenicity of BNT162b2 vaccine after two and three doses in health personnel and institutionalized elderly people not infected with SARS-CoV-2

Journal Title: Medicina de Familia. SEMERGEN

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.semerg.2023.102092

Content Type: article

Copyright: © 2023 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U. All rights reserved.